Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract

Urologia Internationalis

Volumn 86, Issue 1, 2011, Pages 36-40

  Vom Dorp, Frank ^a,d   Pal, Philip ^a   Tschirdewahn, S ^a   Rossi, Roberto ^a   Borgermann C ^b   Schenck, Markus ^a   Becker, Markus ^a   Szarvas, Tibor ^a   Hakenberg, Oliver W ^c,d   Rübben, Herbert ^a,d  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b Städtische Krankenanstalten ^*  (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Sektion Urinzytologie und Uringebundene Tumordiagnostik des Arbeitskreises Onkologie   (Germany)

Author keywords

Bladder cancer; Cytology; Cytometry

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CELL NUCLEUS; CYTODIAGNOSIS; CYTOMETRY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NUCLEAR SIZE; NUCLEOLUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; URINE CYTOLOGY;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; NEOPLASM STAGING; UROLOGIC NEOPLASMS;

EID: 79951810476     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321017     Document Type: Article

References (11)

1. Herr HW, Donat SM, Dalbagni G: Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 2002; 168: 978-980.
2. RUTT Essener Harnwegstumorregister. Jahresbericht Verh Dtsch Ges Urol, 1985, vol 37, p 665.
3. Rübben H, Bubenzer J, Bokenkamp K, Lutzeyer W, Rathert P: Grading of transitional cell tumors of the urinary tract by urine cytology. Urol Res 1979; 7: 83-91. (Pubitemid 9243844)
4. Mian C, Lodde M, Comploij E, Palermo S, Mian M, Maier K, Pycha A: The value of ImmunoCyt/ uCyt+ in the detection and followup of carcinoma in situ of the urinary bladder. Anticancer Res 2005; 25: 3641-3644. (Pubitemid 41105255)
5. Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, Knuechel R, Karl A, Tritschler S, Zaak D: Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007; 69: 260-264. (Pubitemid 46274934)
6. van der Poel HG, Boon ME, Kok LP, Talboom J, van der Meulen B, Ooms EC: Can cytomorphometry replace histomorphometry for grading of bladder tumors? Virchows Arch A Pathol Anat Histopathol 1988; 413: 249-255.
7. Glas AS, Roos D, Deutekom M, Zwindermann AH, Bossuyt PMM, Kurth KH: Tumor markers in the diagnosis of primary bladder cancer. A systemic review. J Urol 2003; 169: 1975-1982. (Pubitemid 36576701)
8. Poulakis V, Witzsch U, De Vries HM: A comparison of nuclear matrix protein-22 and bladder tumor antigen test with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false positive results. BJU Int 2001; 88: 692-701.
9. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D, Osher G, Bridge JA, Anderson S, Johansson SL, Lieber M, Soloway M, Flom K: Clinical evaluation of a multi-target fluorescent in situ hybridisation assay for detection of bladder cancer. J Urol 2002; 168: 1950-1954.
10. Soloway MS, Bruck DS, Kim SS: Expectant management of small, recurrent, non-invasive papillary bladder tumors. J Urol 2003; 170: 438-441. (Pubitemid 36870219)
11. Gofrit ON, Pode D, Lazar A, Katz R, Shapiro A: Watchful waiting policy in recurrent TaG1 bladder tumors. J Urol 2006; 49: 303-306. (Pubitemid 43197869)